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A B S T R A C T
Salmonella species are facultative intracellular pathogens that most frequently cause self-limiting
gastrointestinal disease, often acquired through the ingestion of contaminated food. We report the case
of a 33-year-old otherwise healthy, not overtly immunosuppressed, man who was transferred to our
facility with the chief complaint of respiratory failure and septic shock. Computed tomography of the
chest revealed multifocal pneumonia in both lungs. A bronchial alveolar lavage was performed in the
right middle lobe and cultures predominantly grew Salmonella enterica serovar Enteritidis. The patient
received a prolonged course of antimicrobials, ultimately changing to oral levoﬂoxacin. The etiology of
the salmonella infection likely occurred through an aspiration event. Salmonella species are not a typical
respiratory pathogen in immunocompetent hosts; however, clinicians should be aware of the possibility
that salmonella species may be a pathogenic source of infection in the lungs; a prolonged course of
antimicrobials may be warranted.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Salmonellosis may present with varying clinical infections from
gastroenteritis to enteric fever [1]. According to the Centers for
Disease Control and Prevention (CDC), salmonellosis is estimated
to cause one million cases of illness in the United States, with
19,000 hospitalizations and 380 deaths annually [2]. Pneumonia,
however, is an atypical site for salmonellosis. Most individuals
infected with the bacterium develop fever, abdominal cramps, and
diarrhea between 12 and 72 h after infection. The illness manifests
as gastrointestinal distress and generally lasts 4–7 days; however,
more severe infections can invade into the blood stream and cause
bacteremia with the possibility of disseminated focal infection. The
severity and risk of translocation are often determined by the
virulence of the isolate and host immunity [1]. In severe cases
patients are at risk of death if not promptly treated with
antimicrobials. Infants, elderly, and individuals who are* Corresponding author at: University of Kentucky HealthCare, Department of
Pharmacy Services, 800 Rose Street H110, Lexington, KY 40536, USA.
E-mail address: mlthompson@uky.edu (M.L. Thompson Bastin).
http://dx.doi.org/10.1016/j.idcr.2016.10.004
2214-2509/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article unimmunocompromised are more likely to present with severe
illness from salmonellosis [2].
Case report
A 33-year-old white male with an intellectual disability residing
in a community group home was admitted to an outside hospital
with nausea, vomiting, and diarrhea and was found to be
hypotensive with acute kidney injury (AKI) and a serum creatinine
of 5 mg/dL. Past medical history was signiﬁcant for hypertension,
schizophrenia, depression, anxiety, and seizures. The patient’s
medication history directly from the patient’s group included
metoprolol tartrate, mirtazapine, prazosin, sertraline, cyprohepta-
dine, vitamin D supplement, multivitamin, divalproex sodium,
quetiapine and pantoprazole. At the time of admission he was not
known to have any medication allergies, except a possible
intolerance to phenytoin.
While at the outside hospital, his respiratory status quickly
declined requiring emergent intubation and transfer to the ICU. A
computed tomography (CT) of his abdomen revealed diffuse
edema in the rectum, colon, and small bowel, as well as
vasoconstriction of the mesenteric arteries. Due to the patient’s
elevated lactate of 6 mmol/L an exploratory laparotomy wasder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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intravenous linezolid, meropenem and metronidazole prior to
transfer due to septic shock with suspected abdominal or
pulmonary source. In addition, he underwent hemodialysis prior
to transfer due to oliguric AKI with severe metabolic acidosis.
Two days after initial admission, the patient arrived at our
facility and was found to be febrile, hypotensive with septic shock
and multiple organ failure. Maximum recorded temperature on
admission was 102.2 F. The patient had a leukocytosis with a white
blood cell count of 18.2 k/uL (normal range 3.7–10.3 k/uL)
comprised of: neutrophils 81% (normal range 34–71%), lympho-
cytes 7%, (normal range 20–55%), and eosinophils 0% (normal
range 1–7%). The immature granulocyte count was 2%, (normal
range 0–1%). Renal function tests were found to be abnormal with
serum creatinine 2.59 mg/dL (normal range 0.80-1.3 mg/dL) and
blood urea nitrogen 23 mg/dL (normal range 7–21 mg/dL). Liver
function tests were also abnormal with aspartate aminotransferase
(AST) elevated at 2035 U/L (normal 12–40U/L), alanine amino-
transferase (ALT) 704 U/L (normal 11–41 U/L), alkaline phosphatase
normal at 79 U/L (normal 40–115U/L) and total bilirubin 0.4 mg/dL
(normal 0.2–1.1 mg/dL). The patient’s initial lactate level at our
facility was elevated at 9.5 mmol/L, which was increased from the
documented lactate at the outside hospital and the arterial pH was
measured at 7.07. A procalcitonin level was substantially elevated
at 157.8 ng/mL. His hypotension persisted with a mean arterial
pressure (MAP) 62, on norepinephrine and phenylephrine
infusions. He was also found to have rhabdomyolysis with a
creatinine kinase of >20,000 U/L (normal 52–336 U/L). The patient
had a partial pressure of oxygen to fraction of inspired oxygen
(PaO2/FiO2) ratio of 71 on 100% oxygen.
Upon admission, the patient was also begun on continuous
renal replacement therapy for treatment his acute oliguric renal
failure and metabolic acidosis. He was continued on broad-
spectrum empiric antimicrobials that included vancomycin,
cefepime, metronidazole, and micafungin for possible pneumonia
or abdominal source. A urinalysis was unremarkable. The patient
was noted to have altered mental status, for which the differential
diagnosis included possible seizures considering the patient’s
PMH, potential anoxic brain injury due to the respiratory arrest. A
serum valproic acid level was drawn to assess possible toxicity andTable 1
Antimicrobial Minimum Inhibitory Concentration results for S. Enteritidis and 
Pathogen Antibiotic 
90% Salmonella Enteritidis Ampicillin 
Trimethoprim/Sulfamethoxa
Ceftriaxone 
Levoﬂoxacin 
10% Klebsiella Pneumoniae Amikacin 
Ampicillin 
Ampicillin/Sulbactam 
Aztreonam 
Cefazolin 
Cefepime 
Cefuroxime 
Gentamicin 
Levoﬂoxacin 
Meropenem 
Piperacillin/Tazobactam 
Tetracycline 
Tobramycin 
Trimethoprim/Sulfamethoxa
Ertapenem 
a Susceptibility testing and isolate identiﬁcation performed by BD PhoenixTMreturned at 4 m/mL (normal therapeutic range 50–100 m/mL). CT of
the head was negative for any acute changes. Intravenous acyclovir
was added to the patient’s empiric antimicrobial regimen on day
2 for possible viral encephalitis. Due to the severity of the patient’s
illness and reported hobbies of ﬁshing and outdoor stream and
river exposure, doxycycline was empirically added for possible
tick-borne disease. Both acyclovir and doxycycline were discon-
tinued after 2 days of therapy and no change in clinical status. A
two-dimensional transthoracic echocardiogram was completed
with no signiﬁcant ﬁndings. Blood and urine cultures were
negative.
On day 1 of the patient’s hospital course at our institution, the
patient had a severe pneumonia with elevated WBC, purulent
tracheal secretions, PaO2:FiO2 71, and chest radiograph indicating
very low lung volumes with signiﬁcant atelectasis. CT of the chest
was performed on day 2 and revealed multifocal bilateral
pneumonia. Subsequent bronchoscopy identiﬁed mucus plugs in
the right middle lobe, right lower lobe, and left lower lobe and a
bronchial alveolar lavage (BAL) was done on the right middle lobe.
A potassium hydroxide preparation was performed on the BAL
specimen and revealed no fungal elements; micafungin was
discontinued after 4 days of therapy. A Gram stain was performed
on the BAL specimen and revealed rare epithelial cells, rare white
blood cells and no micro-organisms. An acid fast bacterium stains
on the BAL ﬂuid and subsequent AFB culture was negative. On day
5 the culture from the BAL predominantly revealed a non-lactose
fermenting Gram negative rod as well as some K. pneumoniae. The
antimicrobial regimen was narrowed to cefepime plus a single
dose of tobramycin while awaiting susceptibilities of the Gram-
negative pathogen. At this time, the chest radiograph indicated
persistent but improving right upper lobe airspace disease with
mild worsening patchy left lung airspace disease. The non-lactose
fermenting Gram-negative bacillus was identiﬁed as a salmonella
and reference laboratory speciation found it to be Salmonella
enterica serovar Enteritidis (S. Enteritidis).
Empiric antimicrobials were de-escalated on day 6 based on the
results of susceptibility testing (Table 1). In total, the patient
received 6 days of parenteral cefepime followed by 10 days of oral
levoﬂoxacin. It should be noted that according to the ﬁnal
susceptibility results of both the K. pneumoniae and S. EnteritidisK. Pneumoniae recovered via Bronchial Alveolar Lavage Culture.
Minimum Inhibitory Concentration (mcg/ml)a
>16 Resistant
zole 0.5/9.5 Susceptible
0.047 Susceptible (ETEST)
1 No CLSI Range
8 Susceptible
16 Resistant
8/4 Susceptible
2 Susceptible
2 Susceptible
1 Susceptible
4 Susceptible
2 Susceptible
1 Susceptible
1 Susceptible
4/4 Susceptible
2 Susceptible
2 Susceptible
zole 0.5/9.5 Susceptible
0.5 Susceptible
 Automated Microbiology System.
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was treated with cefepime for a total of 6 days prior to the de-
escalation to levoﬂoxacin. By the ﬁnal day of antimicrobials, the
patient was afebrile, his WBC had decreased to 13.6k/uL and was
tolerating ventilation through a tracheostomy prior to weaning
from the ventilator. Follow up respiratory cultures did not grow
any salmonellae. No stool cultures were initially obtained and later
stool cultures as well as stool comprehensive PCR testing did not
show evidence of salmonellae or any other pathogens. The patient
was transferred on day 28 to a long-term acute care rehabilitation
facility. At the time of discharge the patient was afebrile, stable on
room air, tolerating a speech valve through his tracheostomy
stating that he felt well.
Discussion
Non-typhoid salmonellae (NTS) are present in industrialized
nations and are associated with contaminated food products [3].
NTS infects and colonizes a wide range of animal hosts and human
disease generally manifests as self-limiting gastroenteritis. Salmo-
nella are acid susceptible and must survive the gastric acid barrier
and traverse a mucosal barrier before invading intestinal epithelial
cells [1]. Previous gastric surgery and medications that reduce
gastric acidity increase susceptibility to NTS infection [4]. Once the
bacterium has evaded the gastric acid and mucosal barriers, it
invades intestinal epithelial cells through a process called bacteria-
mediated endocytosis [5]. The innate immune system is activated
by multiple pro-inﬂammatory pathways including activation of
toll-like receptor (TLR)-4 in the presence of lipopolysaccharide on
the cell surface, TLR-5 by bacterial ﬂagellin, and secretion of
interleukin (IL)-b [6]. Resultant intestinal inﬂammation isTable 2
Previous reports S. Enteritidis pneumonia in medical literature.
Patient Presentation Immune status/
Risk factors
Our case Septic shock, pneumonia source Previously healthy.
Developmental
disability
24 YO male
[12]
Back pain, fevers, rigors None, possible
food-borne
transmission
65 YO male
[13]
Diarrhea, cramps, vomiting Ingested
undercooked eggs,
cigarette smoker.
Undiagnosed
diabetes
59 YO female
[13]
Fever, cough Undiagnosed
diabetes
72 YO male
[19]
10 months post diagnosis of small cell lung
cancer; admitted with low grade fever,
dyspnea, tachypnea, chest discomfort, and a
productive cough with purulent sputum
Lung cancer 
26 YO male
[20]
2 day history of fever, non-productive cough,
back pain
and shortness of breath
Hodgkins
lymphoma,
concurrent
chemo-therapy
smokercharacterized by ﬂuid secretion and diarrhea. Salmonellae enter
macrophages in the submucosal space and Peyer’s patches where it
is able to survive and replicate [6]. Components of the cellular
immune system that play a role in clearing salmonella from the
macrophages include interferon- g, IL-12, IL-23, and tumor
necrosis factor-a [7]. Patients with HIV, disorders of oxidative
cellular killing, and sickle cell disease are at higher risk for invasive
NTS disease [8–11].
Pulmonary infections associated with non-typhoid Salmonella
pneumonia in immunocompetent hosts are rare in the medical
literature. A MEDLINE/PubMED (1966 to October 2016) search
limited to the English language and humans using the keywords
Salmonella Enteritidis AND pneumonia AND/OR immunocompe-
tent revealed four detailed reports of S. Enteritidis pneumonia and
are summarized in Table 2.
Hall et al. describe a case of a healthy 24 year old male who
developed severe sepsis, bacteremia and possible pneumonia from
S. Enteritidis acquired from contaminated food [12]. Two cases
summarized by Knight et al. describe S. Enteritidis pneumonia as a
complication of Salmonellosis of the GI track with bacteremia [13].
Neither patient had traditional risk factors for disseminated
Salmonellosis, except one had prior exposure to undercooked
food. Both were newly diagnosed with diabetes during their
hospital stay and were discharged alive with treatment on oral
ciproﬂoxacin. Many reports describe extra-intestinal Salmonello-
sis in patients with known risk factors such as immunosuppres-
sion, living in a developing country, or known exposure to
contaminated food [14–17]. One series described in a Taiwanese
hospital found an association between extra-intestinal salmonel-
losis (including pneumonia) and older age, diabetes and chronic
lung disease [18]. Samonis et al. describe a 72 year old male with aMicrobiology and Antibiotic
Susceptibilities
Treatment/Outcome
S. Enteritidis.
Susceptible to cephalosporins,
ﬂuoroquinolones,
sulfamethoxazole/trimethoprim.
Resistant to ampicillin,
Empiric treatment with cefepime,
convalescent treatment with levoﬂoxacin for
a total of 16 days. Discharged after 28 days to
acute care rehab with tracheostomy
S. Enteritidis. Susceptible to
ciproﬂoxacin, ceftriaxone,
azithromycin
Gluteal abscess and blood cultures also
positive. Received 14d of ceftriaxone followed
by 6 weeks oral ciproﬂoxacin
S. Enteriditis. Susceptibilities not
reported
Developed bacteremia, stool cultures
positive. Empiric treatment with cefuroxime
and erythromycin. Discharged alive on oral
ciproﬂoxacin
S. Enteriditis. Susceptibilities not
reported
Developed bacteremia. Treated with
ciproﬂoxacin, discharged alive.
S. Enteritidis. Susceptible to
ampicillin, ceftazidime,
ceftriaxone, cefotaxime,
ciproﬂoxacin, sulfamethoxazole/
trimethoprim
empiric treatment started with
sulfamethoxazole/trimethoprim,
ceftazidime, and clindamycin; patient
deteriorated, transferred to ICU, developed
ARDS, and expired after 5 days
S. Enteritidis. Susceptible to
cotrimoxazole, ceftriaxone,
meropenem, chloramphenicol,
and ciproﬂoxacin. Resistant to
nalidixic acid and ampicillin.
Empiric treatment with ceftriaxone for 14d,
then discharged home with 14 additional
days of oral ceﬁxime
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pulmonary infection of S. Enteritidis after ﬁve days of treatment
with sulfamethoxazole/trimethoprim, ceftazidime, and clindamy-
cin [19]. The most recent report comes from the Kingdom of
Bahrain [20]. The author describes a case of S. Enteritidis
pneumonia complicated by encysted empyema in a 26 year old
male with Hodgkins lymphoma actively receiving chemotherapy.
He was discharged alive with a 14 day course of a third generation
cephalosporin.
The species isolated in our patient’s case was a common non-
typhoid serovar belonging to group D1 Enteritidis. The ﬁnal
serotyping of this sample was conﬁrmed by Kentucky state
laboratory testing. Other cases have described salmonellosis with
delayed identiﬁcation, serotyping and susceptibility testing of the
pathogen, which can lead to worsening outcomes if proper
antimicrobial therapy is delayed [20,21]. Other documented
serovars isolated from pulmonary sources include Typhimurium,
Derby, Virchow, and Rostock, Dingiri and Abony [15,22–26].
Susceptibility testing of our patient’s S. Enteritidis isolate
revealed resistance to ampicillin and susceptibilities to sulfameth-
oxazole/trimethoprim and levoﬂoxacin. Susceptibility to ceftriax-
one was conﬁrmed via the E-test. Emerging resistance to
sulfamethoxazole/trimethoprim, ﬂuoroquinolones, and some ex-
tended-spectrum cephalosporins has previously been documented
[27]. Our patient was given a 10-day course of levoﬂoxacin after de-
escalating from an empiric regimen of cefepime, metronidazole,
and vancomycin and was eventually discharged from the ICU. The
few detailed reports available on salmonella pneumonia report
difﬁculties in treatment and antimicrobial durations of at least two
weeks [8,19–22,27–30].
The underlying source of the patient’s S. Enteritidis pneumonia
was ultimately never discovered. Salmonellosis can be caused by
contaminated food or handling animals such as reptiles or
amphibians or the environments in which they live. Mermin
et al. reported a population-based, case-control study with data
suggesting that each year 74,000 Salmonella infections may be
associated with reptile and amphibian exposure [31]. The results of
this study concluded that patients with reptile and amphibian
exposure attributed the highest risk of infection of numerous
assessed risk factors commonly thought to cause salmonellosis in
people age 21 or less. The signiﬁcant number of salmonella
infections thought to be caused by amphibian or reptile exposure
in this study coincides with our belief that aquatic animal exposure
could have been a possible source of infection for our patient
infected with S. Enteritidis. Our patient’s primary daily hobby was
ﬁshing, with likely stream and river water exposure. It is unclear if
he had direct contact with aquatic animals such as a turtles, as we
were not able to directly ask the patient at any time during his ICU
stay.
Overall, this case is noteworthy due to the absence of traditional
risk factors associated with severe extra-intestinal disease in the
lung from salmonellosis, including pharmacologic immune sup-
pression, auto-immune disease, known exposure to pathogen-
borne food and living in a developing country [20]. The patient was
only 33 years of age, an age not commonly associated with
pneumonia, septic shock and multi-organ failure. Additionally, the
patient presumably had a functional immune system prior to
admission and was not otherwise overtly immunosuppressed. It is
questionable whether or not the diagnosis of intellectual disability
could have contributed to increasing his risk of contracting the
disease. Our patient did have other risk factors such as taking an
acid suppressing medication (pantoprazole), and lower socioeco-
nomic class [20]. Most other cases of salmonellosis-associated
pneumonia have presented in immunocompromised patients or
patients with a primary pulmonary disorder such as lung cancer or
lupus [8,10,20–22,27–30]. The presumed method of exposure inthis case was from an aspiration event, either prior to admission or
at the time of intubation at the outside hospital.
Conclusion
We report a case of severe S. Enteritidis pneumonia causing
septic shock in a patient with a functional immune system who
was not otherwise immunosuppressed. Clinicians should be aware
of the potential for S. Enteritidis to be a pathogen in the lung, even
in patients without traditional risk factors for S. Enteritidis
infection.
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